| Symbol | SWOBY |
|---|---|
| Name | SWEDISH ORPHAN BIOVITRUM AB |
| Sector | UNDEFINED |
| Region | Europe |
| Industry | - |
| Address | SE-112 76 Sweden Swedish Orphan Biovitrum AB (publ) |
| Telephone | +46 8 697 20 00 |
| Fax | — |
| — | |
| Website | https://www.sobi.com/en |
| Incorporation | SE |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Nasdaq OMX Nordic Exchange Stockholm |
| CIK | 0001452948 |
| Description | Swedish Orphan Biovitrum AB, an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. Additional info from OTC: |
No news found.